Kredo Russo Sharon, SVP of Research & Discovery at COMPUGEN LTD (CGEN), reported ownership changes on March 18, 2026. The filing details direct ownership of 19,500 Ordinary Shares, represented by restricted stock units (RSUs) vesting 50% on December 31, 2027, and the remainder in subsequent quarterly installments, cont...

This Form 3 filing reports the initial statement of beneficial ownership for Anat Cohen-Dayag, a director of Compugen Ltd. The filing discloses her direct holdings in the company's ordinary shares and share options. She owns 108,622 ordinary shares directly, which includes 36,091 restricted stock units (RSUs) that vest...

Pierre Ferre, Chief Operating Officer of COMPUGEN LTD, reported ownership of various share options as of March 18, 2026. These options, granting the right to buy Ordinary Shares, have exercise prices ranging from $3 to $6.45 and expiration dates between 2031 and 2035. The options vest in installments, subject to contin...

This filing details the ownership of securities by Gilead Halevy, a director at COMPUGEN LTD. It includes information on various share options with different exercise dates, expiration dates, and conversion prices, all granting the right to buy Ordinary Shares. Additionally, it reports the direct ownership of 11,407 Or...

This filing details the ownership of Compugen Ltd. by Michele Holcomb, a director. As of March 18, 2026, Holcomb holds 15,000 ordinary shares, represented by restricted stock units (RSUs) that vest starting April 1, 2027. Additionally, Holcomb possesses an option to buy 20,000 ordinary shares with an exercise price of ...

This filing details the ownership changes of Mathias Hukkelhoven, a director at COMPUGEN LTD (CGEN). The report includes information on stock options and ordinary shares. Several stock options with varying exercise dates, expiration dates, and prices are listed. These options are for the right to buy ordinary shares. T...

This Form 3 filing reports the initial statement of beneficial ownership by Zurit Levine, Senior Vice President of Business Development at Compugen Ltd (CGEN). The filing discloses Levine's ownership of 29,375 ordinary shares, which includes 25,821 restricted stock units (RSUs) with various vesting schedules. Additiona...

This filing details the ownership of COMPUGEN LTD (CGEN) by Michelle Mahler, Chief Medical Officer. As of March 18, 2026, Mahler directly holds 23,125 ordinary shares, which includes 20,122 restricted stock units (RSUs). The RSUs have varying vesting schedules, with some commencing in March 2026 and others in September...

This filing details the ownership of COMPUGEN LTD (CGEN) by Eran Ophir, who holds the positions of President, CEO, and Director. The filing indicates direct ownership of 11,375 Ordinary Shares, which includes 7,821 restricted stock units (RSUs) that vest quarterly starting March 31, 2026. Additionally, Mr. Ophir holds ...

This is a Form 3 filing by Eran Perry, a director of Compugen Ltd (CGEN), reporting his initial beneficial ownership of company securities. The filing shows Perry owns 10,000 ordinary shares, which includes 9,216 restricted stock units (RSUs) with various vesting schedules. Additionally, Perry holds multiple share opti...

This filing details the ownership and transaction of securities by Kinneret Livnat Savitzky, a director at COMPUGEN LTD. The report indicates direct ownership of 13,350 Ordinary Shares, which includes 9,216 restricted stock units (RSUs). The vesting schedules for these RSUs vary, with some vesting in quarterly installm...

This filing details stock transactions by David Silberman, Chief Financial Officer of COMPUGEN LTD. The report includes information on restricted stock units (RSUs) and share options. Silberman holds 35,500 ordinary shares, with RSUs vesting partially on September 30, 2026, and the remainder in subsequent installments....